Northwest Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
1,029
-8
-0.8% -$8.17K 0.16% 70
2026
Q1
$954K Buy
1,037
+171
+20% +$173K 0.14% 74
2025
Q4
$931K Sell
866
-20
-2% -$19.1K 0.15% 75
2025
Q3
$676K Buy
886
+35
+4% +$26K 0.11% 93
2025
Q2
$663K Sell
851
-373
-30% -$290K 0.12% 87
2025
Q1
$1.01M Buy
1,224
+40
+3% +$33.3K 0.2% 70
2024
Q4
$914K Buy
1,184
+113
+11% +$93.6K 0.19% 72
2024
Q3
$949K Sell
1,071
-17
-2% -$15.3K 0.22% 72
2024
Q2
$985K Buy
1,088
+16
+1% +$12.8K 0.26% 70
2024
Q1
$834K Buy
1,072
+177
+20% +$126K 0.23% 77
2023
Q4
$522K Buy
895
+211
+31% +$123K 0.16% 89
2023
Q3
$367K Sell
684
-3
-0.4% -$1.55K 0.13% 98
2023
Q2
$322K Sell
687
-33
-5% -$13.8K 0.12% 110
2023
Q1
$247K Sell
720
-38
-5% -$12.8K 0.09% 128
2022
Q4
$277K Sell
758
-397
-34% -$141K 0.12% 114
2022
Q3
$373K Buy
1,155
+89
+8% +$28.2K 0.16% 104
2022
Q2
$346K Buy
1,066
+158
+17% +$47.4K 0.15% 109
2022
Q1
$260K Buy
908
+120
+15% +$30.9K 0.13% 113
2021
Q4
$218K Buy
+788
New +$200K 0.1% 117
2019
Q2
Sell
-935
Closed -$121K 321
2019
Q1
$121K Hold
935
0.09% 142
2018
Q4
$108K Hold
935
0.09% 134
2018
Q3
$100K Hold
935
0.07% 153
2018
Q2
$80K Hold
935
0.06% 170
2018
Q1
$72K Buy
+935
New +$75.3K 0.05% 183

Other funds holding LLY

Northwest Wealth Management's LLY Position: Q2 2026 in Review

Northwest Wealth Management reduced its Eli Lilly (LLY) stake by 0.77% in Q2 2026, selling an estimated $8.17K and leaving 1,029 shares worth $1.23M. The position accounts for 0.16% of the portfolio, ranked #70.

Northwest Wealth Management first reported a position in LLY in Q1 2018 and has held it in 24 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Northwest Wealth Management held 1,029 shares of Eli Lilly worth $1.23M as of Q2 2026.
  • Northwest Wealth Management sold 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.16% of Northwest Wealth Management's portfolio in Q2 2026, its #70 holding.
  • Northwest Wealth Management first reported a position in Eli Lilly in Q1 2018 and has held it in 24 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Northwest Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.